Conference Presentations

American Society for Reproductive Medicine Scientific Congress 2019, Philadelphia, PA

  • P-734:  Infertility patient clinical journey outcome depends on initial treatment, starting with ovulation induction (OI) vs in vitro fertilization (IVF): results from a large real-world database (abstract)
  • P-737:  Insights into infertility patient discontinuation of care: results of a nationwide survey (abstract)
  • P-743:  Factors associated with a patient’s decision to discontinue fertility treatment before achieving pregnancy (abstract)

Society for Reproductive Investigation Annual Scientific Meeting 2019, Paris, France

  • F-212:  The Probability of Clinical Pregnancy in Recipients of Donor Oocytes is Dependent Upon Donor Oocyte Lot Size (abstract)
  • S-212:  Is Intramuscular Progesterone Adequate Luteal Support for Women at Risk for Ovarian Hyperstimulation Syndrome When hCG is Withheld (abstract)
  • S-213:  Live Birth Weight and Gestational Age in Fresh vs. Frozen Blastocyst Embryo Transfers (abstract)

American Society for Reproductive Medicine Scientific Congress 2018, Denver, CO

  • O-1: Three-arm RCT: vaginal only progesterone is inferior, but vaginal plus intramuscular (IM) progesterone every third day is equivalent, to daily IM progesterone for vitrified-warmed blastocyst transfer in terms of live birth (abstract),  *Scientific Congress Prize Paper
  • O-10:  African American patients experience reduced pregnancy, higher pregnancy loss, and lower live birth from IVF embryo transfers despite producing more oocytes and more transfer quality embryos than Caucasian patients (abstract), *Health Disparities Special Interest Group Prize Paper
  • O-12:  Lower gestational age and increased risk of preterm birth associated with singleton live birth resulting from in vitro fertilization (IVF) among African American versus comparable Caucasian women (abstract)
  • O-37:  Near futility of rescue intracytoplasmic sperm injection (ICSI) and the advantage of vitrification over fresh transfer (abstract)
  • O-43:  Natural cycle intrauterine insemination (IUI) versus ovulation induction (OI) IUI for non-infertile women (abstract)
  • O-68:  Mature follicle count and multiple gestation risk based on patient age in ovulation induction-intrauterine insemination (OI-IUI) cycles (abstract)
  • O-163:  Birth rates following euploid blastocyst transfer declines rapidly with previous unsuccessful transfers of euploid blastocysts (abstract)
  • P-793:  Euploid blastocysts undergoing single vitrification have higher live birth rates than those vitrified twice (abstract)

Society for Reproductive Investigation Annual Scientific Meeting 2018, San Diego, CA

  • S-215:  Advanced Paternal Age May Be a Minor Contributor to Aneuploidy Risk in IVF Conception (abstract)

Pacific Coast Reproductive Society Annual Meeting 2018, Indian Wells, CA

  • P-21 Blastocyst freeze-all strategy versus fresh transfer in anonymous oocyte donation cycles (abstract)

American Society for Reproductive Medicine Scientific Congress 2017, San Antonio, TX

  • O-199:  Vitrified blastocyst transfer (FBT) cycles using only vaginal progesterone replacement have inferior ongoing pregnancy rates (OPR): a planned interim analysis of a three-arm randomized controlled non-inferiority trial (RCT) (abstract)
  • O-219:  Exposure to ambient air pollution and live birth outcomes in women undergoing in vitro fertilization (abstract)
  • O-235:  The impact of elective single (ESET) and double (DET) embryo transfers on live and associated multiple birth rates for fresh and frozen/thawed transfers: results from a large real-world database (abstract)

Pacific Coast Reproductive Society Annual Meeting 2017, Indian Wells, CA

  • P-62 Treatment decision trends in the infertility patient journey from 78,958 cycles in a real-world database: impact of age, diagnosis, and year of treatment (abstract)
  • P-11 Weighing the impact of eset versus det on live birth rates and associated multiple rates for 38,020 day 5/6 transfers in a large real-world database (abstract)
  • P-64 Larger donor oocyte cohorts maximize potential number of live born infants per retrieval among recipient in vitro fertilization (IVF) patients (abstract)

American Society for Reproductive Medicine Scientific Congress 2016, Salt Lake City, UT

  • O-88:  Retrieval of larger oocyte cohorts maximizes in vitro fertilization (IVF) birth rates per cycle (abstract)
  • O-128:  Change in day of embryo transfer (ET) by age and primary diagnosis in a real-world US database study of 66,051 transfers over 6.5 years (abstract)
  • O-132:  Evaluating pregnancy and live birth outcomes in a real-world analysis of a US database of 66,051 transfers over 6.5 years (abstract)
  • O-244:  The impact of race and ethnicity on assisted reproductive technology (ART) outcomes: a retrospective cohort study (abstract)
  • P-111:  Aneuploidy rates do not differ between blastocysts biopsied on day 5 (D5) versus day 6 (D6) (abstract)
  • P-170:  FMR1 CGG repeat length and ovarian function in a donor population (abstract)
  • P-174:  Effect of elevated progesterone on day of trigger on live birth with a day 5 versus day 6 blastocyst transfer (abstract)
  • P-208:  Is the progesterone to oocyte ratio a better predictive tool for ART success than progesterone alone? (abstract)
  • P-234:  Temporal changes in oocyte donor treatment regimens in a real-world analysis of a US database of 7971 donor cycles over 6.5 years (abstract)
  • P-419:  BMI is not associated with aneuploidy in patients undergoing preimplantation genetic screening (PGS) (abstract)
  • P-605:  Is endometrial pattern associated with serum progesterone and live birth during IVF? (abstract)
  • P-628:  Evaluating change in gonadotropin-releasing hormone analog (GnRH) use in a US real-world database study of 96,446 in vitro fertilization cycles over 6.5 years (abstract)

American Society for Reproductive Medicine Annual Meeting 2015, Baltimore, MD

  • O-20:  Redefining and clarifying the relationship between total motile sperm counts (TMSC) and intrauterine insemination (IUI) pregnancy rates (abstract), *Society for Male Reproduction and Urology Traveling Scholars Program Prize Paper
  • O-147:  Blastocyst transfer in women aged 40 years or older: how many is too many? (abstract)
  • P-287: FMR1 CGG repeat length and ART outcomes (abstract)
  • P-321:  Discordant Antimullerian hormone (AMH) and follicle stimulating hormone (FSH) and pregnancy outcomes (abstract)
  • P-394:  Pre-wash sperm morphology predicts IUI outcomes by predicting post-wash total motile sperm count (TMSC): an analysis of 26,373 IUI cycles (abstract)
  • P-399:  Too much of a good thing? High motile sperm concentrations may reduce conventional insemination in vitro fertilization (CI-IVF) birth (abstract)
  • P-421:  Elevated baseline follicle stimulating hormone (FSH) is not associated with increased spontaneous abortion (SAB) or aneuploidy in younger patients (abstract)
  • P-482:  128 Autologous post-vitrification oocyte thaw cycles: warming, embryonic development, and pregnancy outcomes (abstract)

American Society for Reproductive Medicine Annual Meeting 2014, Honolulu, Hawaii

  • O-8:  The effect of donor oocyte recipient obesity on live birth: an analysis of 3,922 shared donor oocyte assisted reproductive technology (ART) cycles (abstract)
  • O-122:  Import and export of frozen donor oocyte bank: does transportation affect survival and pregnancy rates? (abstract)
  • O-325:  Improvement of in vitro fertilization (IVF) oocyte to live birth efficiency (abstract)
  • P-478:  Exogenous gonadotropins for poor endometrial responders (abstract)
  • P-524:  Blastocyst quality can select older patients up to and including 40 years of age for successful elective single embryo transfer (eSET) (abstract)
  • P-605:  Diminished ovarian reserve predicts pregnancy loss in older but not younger patients undergoing ART (abstract)

American Society for Reproductive Medicine Annual Meeting 2013, Boston, MA

  • O-43:  A retrospective comparison of slow freezing versus vitrification among a series of 4,596 blastocyst freeze-thaw transfers (abstract)
  • O-46:  Single thawed blastocyst transfer maximizes liveborn children per embryo while minimizing preterm birth: analysis of 1691 frozen blastocyst transfers (FBT) (abstract)
  • O-50:  The association between embryo cryodamage and outcomes of cryopreserved blastocyst transfer following slow freezing and vitrification (abstract)
  • O-231:  Single and double donor sperm intrauterine insemination cycles for male factor infertility: does double IUI increase clinical pregnancy rates? (abstract)
  • O-266:  Race/ethnicity associated with increased peak endometrial thickness and decreased live birth rate: an analysis of 4,086 assisted reproductive technology (ART) cycles (abstract)
  • P-72:  Clinical use of vitrified oocytes among autologous in vitro fertilization (IVF) patients: a three year review (abstract)
  • P-830:  Relationship between endometrial thickness and assisted reproductive technology (ART) outcomes in endometriosis patients (abstract)
  • P-1078:  Increased live births among patients using intamuscular versus vaginal progesterone for luteal phase support during frozen blastocyst transfer (abstract)
  • P-1327:  Rescue intracytoplasmic sperm injection (ICSI) performed following failed conventional inseminationor delayed oocyte maturation results in favorable clinical pregnancy rates (abstract)

Canadian Fertility & Andrology Society Annual Meeting 2013, Victoria, British

  • Excellent outcomes in 4773 donor egg transfers despite fewer oocytes and fewer embryos transferred due to shared donor oocytes, egg banking and elective single embryo programs

American Society for Reproductive Medicine Annual Meeting 2012, San Diego, CA

  • O-8:  Clomid-gonadotropin ovarian hyperstimulation and intrauterine insemination: efficacy with multiple cycles (abstract)
  • O-49:  After two failed IVF cycles in patients under 35, transfer of three embryos rather than two dramatically increases multiple gestation without improving pregnancy rates (abstract)
  • O-151:  Waiting for pregnancy test results following in vitro fertilization and embryo transfer (IVF/ET) or intrauterine insemination (IUI): will giving patients a card help them cope? (abstract)
  • O-168:  Clinical outcomes stratified by serum follicle stimulating hormone (FSH) level in women with low, satisfactory, and high serum anti-mullerian hormone (AMH) levels from multiple fertility centers (abstract)
  • O-170:  Human chorionic gonadotropin (hCG) re-trigger following a poor response to leuprolide acetate (LA) trigger is not associated with poor in vitro fertilization (IVF) treatment outcomes (abstract)
  • O-175:  Matched samples comparison of in vitro fertilization (IVF) clinical outcomes associated with leuprolide acetate (LA) versus human chorionic gonadotropin (hCG) trigger for oocyte maturation (abstract)
  • O-248:  A survey of the experiences and attitudes of healthy fertile donors of oocytes used for in vitro fertilization (IVF) treatments of infertile patients (abstract)
  • O-258:  In vitro fertilization (IVF) yields much higher success rates than intrauterine insemination (IUI) among older women aged 38-44 years (abstract)
  • O-281:  Elevated serum progesterone on the day of human chorionic gonadotropin (hCG) trigger negatively impacts implantation in both cleavage and blastocyst embryo transfers (abstract)
  • O-331:  Trophectoderm grade, but not inner cell mass grade, is predictive of outcomes in single blastocyst transfers (abstract)
  • O-346:  The number of supernumerary vitrified blastocysts is positively correlated to implantation in single blastocyst transfers (abstract)
  • P-204:  Dramatic program-wide reduction in the incidence of severe ovarian hyperstimulation syndrome (OHSS) requiring paracentesis with selective use of gonadotropin-releasing hormone (GnRH) agonist trigger (abstract)
  • P-207:  Characteristics predictive of failed leuprolide acetate (LA) trigger among patients undergoing gonadotropin-releasing hormone (GnRH) antagonist suppression for vitro fertilization (IVF) (abstract)
  • P-423:  A shared risk (SR) refund program for in vitro fertilization (IVF) treatment receives strong endorsement from participants (abstract)
  • P-533:  The simplified SART embryo scoring system is highly correlated to implantation and live birth in single blastocyst transfers (abstract)

American Society for Reproductive Medicine Annual Meeting 2011, Orlando, FL

  • O-213:  Racial/ethnic disparities in assisted reproductive technology (ART) outcomes: an analysis of 10,413 patients from a single fertility practice (abstract)
  • P-241:  Diminished ovarian reserve is not independently associated with clinical reproductive loss in pregnancies achieved by assisted reproductive technologies (ART) (abstract)

American Society for Reproductive Medicine Annual Meeting 2010, Denver, CO

  • O-82:  A diagnosis of polycystic ovary syndrome (PCOS) is associated with an increased likelihood of pregnancy loss with assisted reproduction (abstract)
  • O-224:  Minnesota Multiphasic Personality Inventory 2 (MMPI-2) supplementary scale profiles of applicants to a gestational carrier (GC) program (abstract)
  • O-282:  Oocyte to live birth efficiency of autologous in vitro fertilization (abstract)
  • P-8:  The incidence of genuine empty follicle syndrome (abstract)
  • P-110:  Improvement in diagnostic accuracy using single nucleotide polymorphism (SNP) microarrays versus fluorescence in situ hybridization (FISH) in preimplantation genetic screening (PGS) for aneuploidy (abstract)
  • P-334:  Does obesity cause abnormal endometrial development? (abstract)
  • P-400:  Association between ethnicity and peak endometrial thickness in intrauterine insemination cycles (abstract)
  • P-401:  Defining “endometrial factor” infertility: pregnancy rates following 2,090 intrauterine insemination cycles correlate with endometrial thickness (abstract)
  • P-410:  Redefining the mouse embryo assay (MEA): novel time-lapse imagery and continuous surveillance vs. ‘snap shot’ observation (abstract)
  • P-496:  Relationship between semen parameters and outcome of intrauterine insemination (IUI) (abstract)
  • P-508:  Effect of semen sample collection site on semen analysis parameters and intrauterine insemination (IUI) pregnancy rates (abstract)
  • P-568:  Donor oocyte to live birth efficiency is enhanced by donor sharing (abstract)

European Society for Human Reproduction and Embryology Annual Meeting 2010, Rome, Italy

  • O-152:  Improved preimplantation development and higher pregnancy rates associated with 6% versus ambient oxygen concentration during in vitro embryo culture (abstract)
  • P-418:  Encouraging initial experience with donor oocyte banking through vitrification

Canadian Fertility & Andrology Society Annual Meeting 2010, Vancouver, British Columbia

  • Elective Single Embryo Transfer (eSET): experience with more than 1500 cycles of blastocyst eSET over 8 years, Jan 2002- Dec 2009
  • Improved efficiency and reduced treatment costs with similar pregnancy rates per cycle via 2- and 3-way sharing of donor oocyte cohorts

Society for Gynecological Investigation Annual Scientific Meeting 2010, Orlando, FL

  • Subclinical Hypothyroidism Does Not Adversely Affect Pregnancy Outcomes After Assisted Reproduction

American Society for Reproductive Medicine Annual Meeting 2009, Atlanta, GA

  • O-13:  Proceeding to oocyte retrieval compared to conversion to IUI improves live birth rates in low responding patients (abstract)
  • O-117:  Minnesota multiphasic personality inventory 2 (MMPI-2) profiles of applicants to a gestational carrier (GC) program (abstract)
  • O-144:  Effect of air quality on assisted human reproduction (abstract)
  • P-42:  Pregnant patients with ovarian hyperstimulation syndrome have lower human chorionic gonadotropin levels and doubling time (abstract)
  • P-323:  Is anti-mullerian hormone (AMH) a predictor of ovarian response in infertile women < 35 years of age with an elevated day 3 FSH level? (abstract)

American Society for Reproductive Medicine Annual Meeting 2008, San Francisco, CA

  • O-191:  Conversion from in vitro fertilization (IVF) to intrauterine insemination (IUI) in low responders: is it worth it? (abstract)
  • P-161:  Does D&C versus expectant management for spontaneous abortion in patients undergoing IVF affect subsequent endometrial development? (abstract)
  • P-325:  Analysis of biochemical and biophysical risk factors for monozygotic twinning observed within an in vitro fertilization program (abstract)
  • P-599:  Increased oocyte cohort size at retrieval for in vitro fertilization is associated with a higher proportion of aneuploid embryos (abstract)
  • P-777:  The role of financial cost in patient selection of elective single embryo transfer (ESET) vs. double blastocyst embryo transfer (DBT) (abstract)
  • P-823:  Three-way sharing in an oocyte donation program: expanding availability and reducing treatment costs without compromising pregnancy rate per transfer, resulting in 161% pregnancy rate per retrieval (abstract)
  • P-665:  Subcutaneous recombinant human chorionic gonadotropin (rhCG SQ) trigger for in-vitro fertilization is associated with decreased oocyte maturity compared to intramuscular purified urinary hCG (uhCG IM) (abstract)

Pacific Coast Reproductive Society Annual Meeting 2008, Rancho Mirage, CA

  • O-5 Centriole Abnormalities and Aneuploidy in Sperm From Couples Undergoing IVF (In Vitro Fertilization) (abstract)

American Society for Reproductive Medicine Annual Meeting 2007, Washington, DC

  • O-68:  Elective single embryo transfer (eSET): successful progressive implementation of 450 cycles of eSET among 12,135 IVF-ET cycles from 2002 – 2006 nearly eliminated twin pregnancies among select patients (abstract)
  • O-227:  Demographic variables in relation to outcome in anonymous oocyte donor recruitment (abstract)
  • O-256:  Relative predictive value of patient age, follicle-stimulating hormone (FSH) and antral follicle count (AFC) for response to ovarian stimulation and outcome of in vitro fertilization (IVF) treatment (abstract)
  • P-469:  Recipient age, not paternal age, reduces pregnancy rate in oocyte donation cycles (abstract)

Pacific Coast Reproductive Society Annual Meeting 2007, Rancho Mirage, CA,

  • P-1 Case-Matched Comparison of Intramuscular Versus Vaginal Progesterone for Luteal Phase Support After In Vitro Fertilization and Embryo Transfer (abstract)

American Society for Reproductive Medicine Annual Meeting 2006, New Orleans, LA

  • O-165:  Relationship between endometrial thickness and embryo implantation, based on analysis of 1294 cycles of in vitro fertilization with transfer of two blastocyst stage embryos (abstract)
  • O-175:  Does day 3 embryo grading adequately predict live birth or multiple pregnancy rates? (abstract)
  • P-532:  Single embryo transfer of frozen-thawed blastocysts: Proportion of cells surviving the cryopreservation process is indicative of implantation potential (abstract)
  • P-536:  Does assisted hatching benefit patients with an elevated baseline follicle stimulating hormone (FSH)? (abstract)
  • P-745:  Equivalence of human menopausal gonadotrophin (HMG) and dilute human chorionic gonadotropin (hCG) for luteinizing hormone (LH) activity in ovarian stimulation for in vitro fertilization (abstract)
  • P-916:  Aneuploidy rates of human preimplantation embryos in relation to morphology and development (abstract)
  • P-917:  Differential frequency of aneuploidy among chromosomes detected by preimplantation genetic diagnosis of day 3 embryos (abstract)
  • P-918:  Variation in embryo aneuploidy rates and the indication for preimplantation genetic diagnostic screening (abstract)
  • P-942:  Effect of the maternal age on the percentage of aneuploid chromosomes in biopsied embryos on day 3 (abstract)

American Society for Reproductive Medicine Annual Meeting 2005, Montreal, Quebec

  • O-197:  Preliminary Experience With Elective Single Embryo Transfer (eSET) (abstract)
  • O-219:  The Proportion of Mature Oocytes in a Retrieved Cohort is Positively Correlated With Both Fertilization and Pregnancy Rates After Intracytoplasmic Sperm Injection (ICSI) (abstract)
  • O-230:  Aggressive Outpatient Management of Severe Ovarian Hyperstimulation Syndrome Avoids Complications and Prolonged Disease Course (abstract)
  • P-376:  Selection for Faster Cleavage Rate Does Not Bias Sex Ratios Resulting From Cleavage Stage Embryo Transfer (ET) (abstract)
  • P-507:  Preimplantation Embryo Aneuploidy Rates in Couples Undergoing Donor Egg In Vitro Fertilization Cycles (abstract)
  • P-525:  Correlating Cleavage Stage Embryo Quality With Clinical Outcome Following in Vitro Fertilization (IVF) With Preimplantation Genetic Diagnosis (PGD) and Single Embryo Transfer (SET) (abstract)
  • P-740: Spontaneous Abortion (SAB) of Clinical Intrauterine Pregnancy (IUP) Following in Vitro Fertilization (IVF) Is Not Correlated With Follicle Stimulating Hormone (FSH) (abstract)

American Society for Reproductive Medicine Annual Meeting 2004, Philadelphia, PA

  • O-99:  Risk factors for monozygotic twinning observed within an in vitro fertilization (IVF) program: Biochemical versus biophysical (abstract)
  • P-36:  Examination of success rates of frozen/thaw blastocyst transfer cycles according to the day of blastocyst cryopreservation reveals surprisingly high success rates among blastocysts frozen on day 7 after oocyte retrieval (abstract)
  • P-183:  Pregnancy rates following in vitro fertilization are reduced with a thin endometrium, but are unrelated to endometrial thickness above 10 millimeters (abstract)
  • P-237:  Selection for faster development to the blastocyst stage following in vitro fertilization does not bias human sex ratios (abstract)
  • P-301:  Comparison of embryo development between non-biopsy cycles and laser assisted biopsy cycles for Preimplantation Genetic Diagnosis (PGD) within the same patient population (abstract)
  • P-304:  Embryo development from day 3 to day 5 after laser assisted blastomere biopsy for Preimplantation Genetic Diagnosis (PGD), relative to day 3 embryo quality (abstract)
  • P-305:  Preimplantation genetic diagnosis (PGD) by fluorescence in situ hybridization (FISH) analysis for aneuploidy on more than one hundred in vitro fertilization (IVF) patients: The influence of patient age on pregnancy outcomes (abstract)
  • P-327:  Correlation between spermatozoa aneuploidy and DNA fragmentation in 26 males (abstract)
  • P-329:  Preimplantation genetic diagnosis (PGD) for chromosomes 13, 14, 15, 16, 17, 18, 21, 22, X and Y on 1435 embryos by fluorescence in situ hybridization (FISH): Is there a significant difference between aneuploidy incidence among the tested chromosomes? (abstract)
  • P-359:  Multicenter experience with transfers of embryos produced by rescue intracytoplasmic sperm injection (ICSI) performed on late-maturing oocytes and on oocytes following failed conventional insemination (abstract)
  • P-361:  Preliminary results of a prospective randomized study comparing fertilization outcome and preimplantation embryo development between conventional and laser assisted intracytoplasmic sperm injection (ICSI) (abstract)

American Society for Reproductive Medicine Annual Meeting 2003, San Antonio, TX

  • O-106:  A retrospective analysis of factors influencing oocyte degeneration post-ICSI (abstract)
  • O-247:  Preliminary results of a prospective randomized study to assess the value of laser assisted hatching before cleavage stage embryo transfer among good-prognosis in vitro Fertilization (IVF) patients (abstract)
  • O-297:  Spermatozoa aneuploidy for 15 chromosomes by fluorescence in situ hybridization (FISH) and somatic cell karyotypes from two hundred thirty oligoasthenoteratozoospermic (OAT) males (abstract)
  • P-172:  Timing of presentation with severe OHSS predicts clinical IVF pregnancy (abstract)
  • P-224:  Preimplantation Genetic Diagnosis (PGD) for aneuploidy in women under 38 yrs of age on 142 embryos from 13 initiated cycles using Fluorescence In Situ Hybridization (FISH) (abstract)
  • P-226:  Preimplantation Genetic Diagnosis (PGD) for aneuploidy on 381 embryos from 39 initiated cycles using Fluorescence In Situ Hybridization (FISH) (abstract)

Pacific Coast Reproductive Society Annual Meeting 2003, Rancho Mirage, CA

  • P-12 Granulocyte-macrophage colony-stimulating factor enhances human embryo development to the blastocyst stage: a randomized study (abstract)
  • P-11 Early pregnancy hCG differences associated with the timing of embryo transfer following in vitro fertilization (abstract)

American Society for Reproductive Medicine Annual Meeting 2002, Seattle, WA

  • P-403:  Predictive value of standardized weight adjusted early pregnancy hCG titers following in vitro fertilization (abstract)

Pacific Coast Reproductive Society Annual Meeting 2002, Rancho Mirage, CA

  • O-7 Vero cell coculture with sequential blastocyst media: a randomized controlled study comparing two different cleavage-stage media formulations (abstract)
  • P-29 The correlation between sonohysterographic infusion volume and tubal status (abstract)

American Society for Reproductive Medicine Annual Meeting 2001, Orlando, FL

  • O-8:  A randomized controlled study comparing human embryo growth in sequential blastocyst media with or without Vero cell coculture (abstract)

Pacific Coast Reproductive Society Annual Meeting 2001, Rancho Mirage, CA

  • P-24 Outcome of Repeated Cycles of In Vitro Fertilization With Blastocyst Stage Embryo Transfer (abstract)

American Society for Reproductive Medicine Annual Meeting 2000, San Diego, CA

  • O-111:  Optimal Inner Cell Mass Size and Shape for a Human Blastocyst (abstract)
  • P-42:  Blastocyst Transfer on Day 5 versus Day 6 (abstract)

Pacific Coast Reproductive Society Annual Meeting 2000, Rancho Mirage, CA

  • P-16 A Retrospective Comparison of Day 3 and Blastocyst Transfer (abstract)
  • P-17 Influence of Age on the Outcome of In Vitro Fertilization With Blastocyst Transfer (abstract)
  • P-18 A Single Human Chorionic Gonadotropin Measurement on Day 10 Postretrieval Is Predictive of IVF Outcome (abstract)

American Society for Reproductive Medicine Annual Meeting 1999, Philadelphia, PA

  • O-78:  Apparent Optimal Inner Cell Mass Size for Successful Blastocyst Transfer (abstract)
  • P-49:  Postponing Embryo Transfer Until Blastocyst Formation Does Not Delay Uterine Implantation (abstract)

Pacific Coast Reproductive Society Annual Meeting 1999, Carlsbad, CA

  • O-9 The predictive value of cycle day 3 cell number on blastocyst development, and success of subsequent transfer based upon the degree of blastocyst development (abstract)
  • P-7 Pregnancy rates following blastocyst transfers nearly double among patients using donor eggs (abstract)